Inflammation is common in heart failure (HF), but potential sex differences across HF phenotypes remain uncertain. High-sensitivity C-reactive protein (hsCRP) offers a pragmatic measure of inflammatory burden. Major trials (e.g. CANTOS) have linked a threshold of hsCRP ≥2 mg/L to a persistent inflammatory signal...
S. Stoerk, W. P. Abhayaratna, K. Connelly et al.· European Heart Journal· 0 citations
Cardiac involvement in Fabry disease (FD) manifests as left ventricular hypertrophy (LVH), often complicated by myocardial fibrosis, leading to progressive functional limitation. We aimed to investigate the mechanisms underlying functional impairment in patients with FD cardiomyopathy by examining the relationshi...
G. Guida, G. Disabato, A. Attanasio et al.· European Heart Journal· 0 citations
Cardiovascular diseases (CVDs) are the leading cause of death among women, yet risk awareness remains suboptimal. Results of the 2019 American National Survey showed that awareness that CVDs are the number one killer in women declined from 2009 to 2019. Understanding who is aware—and why—is critical to design eff...
E. Marseglia, G. Guida, L. Ramputi et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.